China SXT Pharmaceuticals (SXTC) Other Non-Current Assets (2019 - 2024)

China SXT Pharmaceuticals' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $8.5 million for Q3 2024.

• In Q3 2024, Other Non-Current Assets changed N/A year-over-year to $8.5 million; the TTM figure through Sep 2024 stood at $8.5 million (changed N/A YoY), while the FY2024 annual figure was $8.3 million, down 4.88% from the prior year.
• Other Non-Current Assets was $8.5 million for Q3 2024 at China SXT Pharmaceuticals, up from $8.3 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $9.5 million in Q1 2022 to a low of $2.9 million in Q3 2020.
• Historically, Other Non-Current Assets has averaged $8.1 million across 5 years, with a median of $8.6 million in 2023.
• The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets surged 225.9% in 2021, then fell 9.42% in 2022.
• A 5-year view of Other Non-Current Assets shows it stood at $2.9 million in 2020, then soared by 225.9% to $9.3 million in 2021, then retreated by 9.42% to $8.4 million in 2022, then advanced by 3.58% to $8.7 million in 2023, then retreated by 2.14% to $8.5 million in 2024.
• The last three Other Non-Current Assets figures came in at $8.5 million (Q3 2024), $8.3 million (Q1 2024), and $8.7 million (Q1 2023), per Business Quant data.